Literature DB >> 23153709

Antituberculosis drug-induced hypersensitivity syndrome and its association with human leukocyte antigen.

Sang-Heon Kim1, Soo-Keol Lee, Sang-Hoon Kim, Heung-Woo Park, Yoon-Seok Chang, Kyung Wha Lee, Young-Koo Jee.   

Abstract

Antituberculosis drug (ATD)-induced hypersensitivity syndrome (HSS) is a serious adverse reaction to ATDs, but much remains to be determined regarding its characteristics and genetic risk factors. In this study, we have collected cases of ATD-induced HSS and their clinical features, and investigated the associations of ATD-induced HSS with human leukocyte antigen (HLA). Subjects with ATD-induced HSS and ATD-tolerant controls were recruited through analysis of a multicenter adverse drug reaction registry in Korea. HLA allele frequencies were compared between subjects with ATD-induced HSS (n = 14) and two control groups: ATD-tolerant controls (n = 166) and the general population (n = 485). The number of enrolled subjects with ATD-induced HSS (n = 14) was comparable to those of patients with HSS induced by other common drugs such as allopurinol during the recruitment period. The frequency of Cw*0401 was much higher in the cases (50.0%) compared with ATD-tolerant controls (12.7%, Pc = 0.0204, OR = 6.90) and the general population (12.8%, Pc = 0.0132, OR = 6.82). Our results suggest that ATD is an important causative agent inducing HSS with distinct clinical features. The strong association of Cw*0401 with the risk for ATD-induced HSS suggests immunological involvement in the development of this syndrome.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153709     DOI: 10.1016/j.tube.2012.10.010

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  6 in total

1.  Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.

Authors:  Mario Sánchez-Borges; Bernard Thong; Miguel Blanca; Luis Felipe Chiaverini Ensina; Sandra González-Díaz; Paul A Greenberger; Edgardo Jares; Young-Koo Jee; Luciana Kase-Tanno; David Khan; Jung-Won Park; Werner Pichler; Antonino Romano; Maria José Torres Jaén
Journal:  World Allergy Organ J       Date:  2013-10-31       Impact factor: 4.084

2.  AdDRESSing T-cell responses to antituberculous drugs.

Authors:  R Pavlos; A Redwood; E Phillips
Journal:  Br J Dermatol       Date:  2017-02       Impact factor: 9.302

3.  Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study.

Authors:  Ho Yeon Jung; Sunmin Park; Beomsu Shin; Ji Ho Lee; Seok Jeong Lee; Myoung Kyu Lee; Won Yeon Lee; Suk Joong Yong; Sang Ha Kim
Journal:  Allergy Asthma Immunol Res       Date:  2019-01       Impact factor: 5.764

4.  Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs.

Authors:  Sang Heon Kim
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

Review 5.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

6.  A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy.

Authors:  Bernard Yu-Hor Thong; Faith Li-Ann Chia; Sze-Chin Tan; Teck-Choon Tan; Khai-Pang Leong; Justina Wei-Lyn Tan; Chwee-Ying Tang; Jin-Feng Hou; Grace Yin-Lai Chan; Hiok-Hee Chng
Journal:  Asia Pac Allergy       Date:  2014-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.